Dunn (SI-Bone director) sells $425k in SIBN stock
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Si-Bone Inc (SIBN)
Assess today's live Si-Bone Inc (SIBN) share price, performance and insights using our live NASDAQ: SIBN stock exchange data.
Analyse the historical data and Si-Bone Inc share price performance charts on this page. Our technical summary section provides analysis on Si-Bone share price buy/sell indicators using real-time data (or discuss the Si-Bone (SIBN) stock price today with other investors in the Si-Bone NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SIBN share price (ISIN: US8257041090) to enhance your trading decisions with our free investment tools and resources.
What Is the Si-Bone Inc Share Price Today?
The Si-Bone share price today is 16.80.
What Is the Stock Symbol for Si-Bone Inc
The stock symbol (or 'ticker') for Si-Bone Inc is "SIBN."
What Stock Exchange Does Si-Bone Inc Trade On?
Si-Bone Inc is listed and trades on the NASDAQ stock exchange.
Is Si-Bone Inc a Good Stock to Buy?
Determining whether Si-Bone Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Si-Bone Inc share price performance charts on this page. Our technical summary section provides analysis on Si-Bone share price buy/sell indicators using real-time data (or discuss the Si-Bone (SIBN) stock price today with other investors in the Si-Bone NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SIBN share price (ISIN: US8257041090) to enhance your trading decisions with our free investment tools and resources.
What Is the Si-Bone Inc Share Price Today?
The Si-Bone share price today is 16.80.
What Is the Stock Symbol for Si-Bone Inc
The stock symbol (or 'ticker') for Si-Bone Inc is "SIBN."
What Stock Exchange Does Si-Bone Inc Trade On?
Si-Bone Inc is listed and trades on the NASDAQ stock exchange.
Is Si-Bone Inc a Good Stock to Buy?
Determining whether Si-Bone Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.44
17.15
52 wk Range
12.50
21.89
SIBN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.4417.15
52 wk Range
12.5021.89
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SIBN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
25.89
Upside
+54.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 8K Si-Bone Inc For: 12 January
- Investing.com
- Si Bone Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Dunn (SI-Bone director) sells $425k in SIBN stock
- Investing.com
- Form 8K Si-Bone Inc For: 12 January
- Investing.com
- Form 144 SI-BONE For: 2 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Si-Bone Company Profile
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Si-Bone Inc SWOT Analysis
Surgical Innovation | SI-BONE's iFuse Implant System drives 22.6% YoY growth, establishing the company as a pioneer in minimally invasive sacroiliac joint surgery |
Financial Health | Strong Q1 2025 performance with $47.3M in sales, 25% YoY increase. Healthy 79.25% gross margin and solid cash position, despite current overvaluation |
Growth Trajectory | Analysts project 15-20%+ annual revenue growth. New product launches and FDA Breakthrough Device Designations poised to expand addressable market |
Market Dynamics | Average analyst price target of $28.50. NTAP reimbursement of $3,960 for iFuse TORQ TNT expected in Q4 2025, potentially catalyzing adoption |
Si-Bone Inc Earnings Call Summary for Q2/2025
- Si-Bone beats Q2 2025 expectations with EPS of -$0.14 and revenue of $48.6M, up 21.7% YoY; stock rises 2.93% after-hours
- Company reports third consecutive quarter of positive adjusted EBITDA; gross margin expands to 79.8%
- Full-year revenue guidance set at $195-$198M, projecting 17-18% growth; positive adjusted EBITDA expected to continue
- Plans to expand sales territories and launch new products in 2026; focus on U.S. market and ASC expansion
- CEO expresses optimism for H2; CFO projects medium-term gross margin stabilization at 76-77%
Last Updated: 04/08/2025, 22:42
Read Full TranscriptCompare SIBN to Peers and Sector
Metrics to compare | SIBN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSIBNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −33.5x | −3.7x | −0.6x | |
PEG Ratio | −0.77 | 0.17 | 0.00 | |
Price/Book | 4.2x | 3.2x | 2.6x | |
Price / LTM Sales | 3.8x | 2.0x | 3.4x | |
Upside (Analyst Target) | 48.8% | 50.5% | 41.5% | |
Fair Value Upside | Unlock | 9.5% | 4.4% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 25.89
(+54.10% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-0.11 / -0.17
Revenue / Forecast
48.70M / 46.67M
People Also Watch
FAQ
What Is the Si-Bone (SIBN) Share Price Today?
The live Si-Bone share price today is 16.80
What Stock Exchange Does Si-Bone (SIBN) Trade On?
Si-Bone is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Si-Bone?
The stock symbol (also called a 'ticker') for Si-Bone is "SIBN."
What Is the Current Si-Bone Market Cap?
As of today, Si-Bone market capitalisation is 728.97M.
What Is Si-Bone's (SIBN) Earnings Per Share (TTM)?
The Si-Bone EPS is currently -0.51 (Trailing Twelve Months).
When Is the Next Si-Bone Earnings Date?
Si-Bone's next earnings report will be released on 02 Mar 2026.
Is SIBN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Si-Bone moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Si-Bone Stock Split?
Si-Bone has split 0 times. (See the SIBN stock split history page for full effective split date and price information.)
How Many Employees Does Si-Bone Have?
Si-Bone has 349 employees.
What is the current trading status of Si-Bone (SIBN)?
As of 25 Jan 2026, Si-Bone (SIBN) is trading at a price of 16.80, with a previous close of 16.92. The stock has fluctuated within a day range of 16.44 to 17.15, while its 52-week range spans from 12.50 to 21.89.
What Is Si-Bone (SIBN) Price Target According to Analysts?
The average 12-month price target for Si-Bone is USD25.89, with a high estimate of USD32 and a low estimate of USD23. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +54.10% Upside potential.
What Is the SIBN Premarket Price?
SIBN's last pre-market stock price is 16.90. The pre-market share volume is 20.00, and the stock has decreased by -0.02, or -0.12%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.